{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T04:04:31Z","timestamp":1747973071640,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,21]]},"DOI":"10.7759\/cureus.84590","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:44:30Z","timestamp":1747889070000},"source":"Crossref","is-referenced-by-count":0,"title":["Disseminated Nocardiosis: Poorly Controlled Diabetes as an Immunocompromising State"],"prefix":"10.7759","author":[{"given":"Danielle G","family":"Iben","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Dobrzynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00027-21","article-title":"Updated review on Nocardia species: 2006-2021","volume":"35","author":"Traxler RM","year":"2022","unstructured":"Traxler RM, Bell ME, Lasker B, Headd B, Shieh WJ, McQuiston JR. Updated review on Nocardia species: 2006-2021. Clin Microbiol Rev. 2022, 35:e0002721. 10.1128\/cmr.00027-21","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1128\/9781555815455.ch13","article-title":"Aerobic actinomycetes","author":"Saubolle MA","year":"2008","unstructured":"Saubolle MA. Aerobic actinomycetes. Diagnostic Microbiology of the Immunocompromised Host. Hayden RT, Carroll KC, Tang YW, Wolk DM (ed): ASM Press, Washington, DC; 2008. 269-82. 10.1128\/9781555815455.ch13"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.11.016","article-title":"Nocardiosis: updates and clinical overview","volume":"87","author":"Wilson JW","year":"2012","unstructured":"Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012, 87:403-7. 10.1016\/j.mayocp.2011.11.016","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00002-18","article-title":"Clinical assessment of a Nocardia PCR-based assay for diagnosis of nocardiosis","volume":"56","author":"Rouzaud C","year":"2018","unstructured":"Rouzaud C, Rodriguez-Nava V, Catherinot E, et al.. Clinical assessment of a Nocardia PCR-based assay for diagnosis of nocardiosis. J Clin Microbiol. 2018, 56:e00002-18. 10.1128\/JCM.00002-18","journal-title":"J Clin Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200209000-00004","article-title":"Nocardiosis in cancer patients","volume":"81","author":"Torres HA","year":"2002","unstructured":"Torres HA, Reddy BT, Raad II, et al.. Nocardiosis in cancer patients. Medicine (Baltimore). 2002, 81:388-97. 10.1097\/00005792-200209000-00004","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012436","article-title":"Manifestations and outcomes of nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients","volume":"97","author":"Steinbrink J","year":"2018","unstructured":"Steinbrink J, Leavens J, Kauffman CA, Miceli MH. Manifestations and outcomes of nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients. Medicine (Baltimore). 2018, 97:e12436. 10.1097\/MD.0000000000012436","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.01.011","article-title":"Nocardia bacteremia: a single-center retrospective review and a systematic review of the literature","volume":"92","author":"Williams E","year":"2020","unstructured":"Williams E, Jenney AW, Spelman DW. Nocardia bacteremia: a single-center retrospective review and a systematic review of the literature. Int J Infect Dis. 2020, 92:197-207. 10.1016\/j.ijid.2020.01.011","journal-title":"Int J Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-0287","article-title":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study","volume":"41","author":"Critchley JA","year":"2018","unstructured":"Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018, 41:2127-35. 10.2337\/dc18-0287","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111023","article-title":"A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin","volume":"207","author":"Chaudhry UA","year":"2024","unstructured":"Chaudhry UA, Carey IM, Critchley JA, et al.. A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin. Diabetes Res Clin Pract. 2024, 207:111023. 10.1016\/j.diabres.2023.111023","journal-title":"Diabetes Res Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1573399815666191024085838","article-title":"Type 2 diabetes and its impact on the immune system","volume":"16","author":"Berbudi A","year":"2020","unstructured":"Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020, 16:442-9. 10.2174\/1573399815666191024085838","journal-title":"Curr Diabetes Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson K","year":"2015","unstructured":"Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015, 144:171-85. 10.1111\/imm.12394","journal-title":"Immunology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678771","article-title":"A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity","volume":"12","author":"Dowey R","year":"2021","unstructured":"Dowey R, Iqbal A, Heller SR, Sabroe I, Prince LR. A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity. Front Immunol. 2021, 12:678771. 10.3389\/fimmu.2021.678771","journal-title":"Front Immunol"},{"key":"ref13","unstructured":"Dengue and severe dengue. (2024). Accessed. March 25, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8091405","article-title":"Zoonotic diseases: etiology, impact, and control","volume":"8","author":"Rahman MT","year":"2020","unstructured":"Rahman MT, Sobur MA, Islam MS, et al.. Zoonotic diseases: etiology, impact, and control. Microorganisms. 2020, 8:1405. 10.3390\/microorganisms8091405","journal-title":"Microorganisms"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy381","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology","volume":"67","author":"Miller JM","year":"2018","unstructured":"Miller JM, Binnicker MJ, Campbell S, et al.. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018, 67:e1-e94. 10.1093\/cid\/ciy381","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.01.005","article-title":"Nocardiosis in the south of France over a 10-years period, 2004-2014","volume":"57","author":"Haussaire D","year":"2017","unstructured":"Haussaire D, Fournier PE, Djiguiba K, et al.. Nocardiosis in the south of France over a 10-years period, 2004-2014. Int J Infect Dis. 2017, 57:13-20. 10.1016\/j.ijid.2017.01.005","journal-title":"Int J Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-03-2646","article-title":"Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease","volume":"64","author":"Danna EA","year":"2004","unstructured":"Danna EA, Sinha P, Gilbert M, Clements VK, Pulaski BA, Ostrand-Rosenberg S. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res. 2004, 64:2205-11. 10.1158\/0008-5472.can-03-2646","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-023-00768-2","article-title":"Immune changes induced by periampullary adenocarcinoma are reversed after tumor resection and modulate the postoperative survival","volume":"14","author":"Landerer A","year":"2023","unstructured":"Landerer A, Himmelsbach R, Biesel EA, Fichtner-Feigl S, Wittel UA, Chikhladze S. Immune changes induced by periampullary adenocarcinoma are reversed after tumor resection and modulate the postoperative survival. Discov Oncol. 2023, 14:153. 10.1007\/s12672-023-00768-2","journal-title":"Discov Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"Steinbrink JM","year":"2021","unstructured":"Steinbrink JM, Miceli MH. Mucormycosis. Infect Dis Clin North Am. 2021, 35:435-52. 10.1016\/j.idc.2021.03.009","journal-title":"Infect Dis Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00284-024-03748-z","article-title":"Diabetes and infectious diseases with a focus on melioidosis","volume":"81","author":"Uthaya Kumar A","year":"2024","unstructured":"Uthaya Kumar A, Ahmad Zan M, Ng CL, Chieng S, Nathan S. Diabetes and infectious diseases with a focus on melioidosis. Curr Microbiol. 2024, 81:208. 10.1007\/s00284-024-03748-z","journal-title":"Curr Microbiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/348884-disseminated-nocardiosis-poorly-controlled-diabetes-as-an-immunocompromising-state","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:44:33Z","timestamp":1747889073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/348884-disseminated-nocardiosis-poorly-controlled-diabetes-as-an-immunocompromising-state"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84590","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,21]]}}}